Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

Keryx Completes Enrolment In Long-Term Phase III Study Of Zerenex - RTT News PDF Print
RTT News
Zerenex is the the company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on dialysis. This Phase 3 long-term study is a multicenter, ...
Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in Zerenex

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.